Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017

Details for Mechanism ID: 10219
Country/Region: Zambia
Year: 2016
Main Partner: Elizabeth Glaser Pediatric AIDS Foundation
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Testing: HIV Testing and Counseling (HVCT) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: 1-9 2017 11
HTS_TST Age/sex: 10-14 Female 2017 1
HTS_TST Age/sex: 15-19 Female 2017 11
HTS_TST Age/sex: 20-24 Female 2017 9
HTS_TST Age/sex: 20-24 Male 2017 1
HTS_TST Age/sex: 25-49 Female 2017 28
HTS_TST Age/sex: 25-49 Male 2017 17
HTS_TST Age/sex: 50+ Female 2017 5
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 7
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 5
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 53
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 18
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 83
HTS_TST Service Delivery Point (Facility): VCT 2017 83
HTS_TST Sum of Age/Sex disaggregates 2017 72
HTS_TST Sum of Aggregated Age/Sex <15 2017 12
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 71
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 83
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 1
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 2
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 4
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 1
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 1
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 2
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 1
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 1
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 6
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 3
PMTCT_ART Already on ART at beginning of current pregnancy 2017 8
PMTCT_ART New on ART 2017 11
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 21
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 19
PMTCT_EID Sum of Infant Age disaggregates 2017 19
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 2
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 19
PMTCT_STAT By: Known positives at entry 2017 7
PMTCT_STAT By: Number of new positives identified 2017 14
PMTCT_STAT Number of new ANC and L&D clients 2017 21
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 21
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 7
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 15-19 2017 2
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 12
PMTCT_STAT Sum of Positives Status disaggregates 2017 21
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 2
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 19
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 92
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 47
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 4
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 2
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 145
TX_CURR Age/Sex: <1 2017 14
TX_CURR Age/Sex: <1-9 2017 127
TX_CURR Age/Sex: 10-14 Female 2017 132
TX_CURR Age/Sex: 10-14 Male 2017 138
TX_CURR Age/Sex: 15-19 Female 2017 127
TX_CURR Age/Sex: 15-19 Male 2017 43
TX_CURR Age/Sex: 20-24 Female 2017 91
TX_CURR Age/Sex: 20-24 Male 2017 205
TX_CURR Age/Sex: 25-49 Female 2017 882
TX_CURR Age/Sex: 25-49 Male 2017 1,508
TX_CURR Age/Sex: 50+ Female 2017 177
TX_CURR Age/Sex: 50+ Male 2017 168
TX_CURR Aggregated Age/Sex: <15 Female 2017 215
TX_CURR Aggregated Age/Sex: <15 Male 2017 196
TX_CURR Aggregated Age/Sex: 15+ Female 2017 2,112
TX_CURR Aggregated Age/Sex: 15+ Male 2017 1,089
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 3,612
TX_CURR Sum of age/sex disaggregates 2017 170
TX_CURR Sum of Aggregated Age/Sex <15 2017 411
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 3,201
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 3,612
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 23
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 19
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 153
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 95
TX_NEW By Age/Sex: 1-9 2017 19
TX_NEW By Age/Sex: 10-14 Female 2017 14
TX_NEW By Age/Sex: 10-14 Male 2017 9
TX_NEW By Age/Sex: 15-19 Female 2017 5
TX_NEW By Age/Sex: 15-19 Male 2017 22
TX_NEW By Age/Sex: 20-24 Female 2017 12
TX_NEW By Age/Sex: 20-24 Male 2017 2
TX_NEW By Age/Sex: 25-49 Female 2017 123
TX_NEW By Age/Sex: 25-49 Male 2017 59
TX_NEW By Age/Sex: 50+ Female 2017 12
TX_NEW By Age/Sex: 50+ Male 2017 13
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 290
TX_NEW Sum of Age/Sex disaggregates 2017 271
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 290
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 903
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 214
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 197
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 325
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 167
TX_PVLS Numerator: Indication: Targeted 2017 903
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 36
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 40
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 24
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 22
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 16
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 142
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 91
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 60
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 40
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 164
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 107
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 371
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 491
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 26
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 6
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 9
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 12
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 17
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 22
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 9
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 196
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 150
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 22
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 22
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 22
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 19
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 252
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 198